The Group's principal activity is developing, manufacturing and marketing prescription and non-prescription pharmaceutical products principally in the areas of neurology and dermatology. The Company's growth strategy is to acquire, develop and commercialize new products through strategic partnerships, and build on the company's market in neurology and dermatology. The Group's markets focus primarily in the United States, Canada, Mexico, Brazil and Australia. Headquartered in Orange County, California, Valeant has approximately 2,331 employees worldwide.
Alacra Alerts:
Receive alerts on the latest reports on Valeant Pharmaceuticals International
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
